BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Vancouver - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://scienceinvancouver.com
X-WR-CALDESC:Events for Science in Vancouver
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200416T130000
DTEND;TZID=America/Vancouver:20200416T134500
DTSTAMP:20260408T195422
CREATED:20200403T202418Z
LAST-MODIFIED:20200403T202418Z
UID:10962-1587042000-1587044700@scienceinvancouver.com
SUMMARY:LARGER THAN LIFE SCIENCE | Race for a Cure
DESCRIPTION:Race for a Cure\nThe Work Behind a Coronavirus Vaccine\nFireside Chat with Claes Gustafsson of ATUM\nAmidst global concerns about the coronavirus outbreak\, Bay Area company ATUM is working around the clock to help find a vaccine. ATUM builds virtual models first to identify different properties of the coronavirus. Sub-pieces of the virus are then sent to collaborators around the world who are working on formulations for a vaccine. In this fireside chat\, hear from ATUM’s Co-Founder\, Claes Gustafsson\, on the technology behind the cure and how the biotech community is banding together for the collective good. \nSpeakers:\nDr. Claes Gustafsson\, Co-Founder and Chief Commercial Officer\, ATUM \nDerrick Rowe\, PhD\, Associate\, Patents and Innovations\, Wilson Sonsini \n••• \nDownload the free Zoom app ahead of time to prepare for the webinar
URL:https://scienceinvancouver.com/event/larger-than-life-science-race-for-a-cure/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/LARGER-THAN-LIFE-SCIENCE-Race-for-a-Cure.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200416T130000
DTEND;TZID=America/Vancouver:20200416T134500
DTSTAMP:20260408T195422
CREATED:20200403T202418Z
LAST-MODIFIED:20200403T202418Z
UID:26130-1587042000-1587044700@scienceinvancouver.com
SUMMARY:LARGER THAN LIFE SCIENCE | Race for a Cure
DESCRIPTION:Race for a Cure\nThe Work Behind a Coronavirus Vaccine\nFireside Chat with Claes Gustafsson of ATUM\nAmidst global concerns about the coronavirus outbreak\, Bay Area company ATUM is working around the clock to help find a vaccine. ATUM builds virtual models first to identify different properties of the coronavirus. Sub-pieces of the virus are then sent to collaborators around the world who are working on formulations for a vaccine. In this fireside chat\, hear from ATUM’s Co-Founder\, Claes Gustafsson\, on the technology behind the cure and how the biotech community is banding together for the collective good. \nSpeakers:\nDr. Claes Gustafsson\, Co-Founder and Chief Commercial Officer\, ATUM \nDerrick Rowe\, PhD\, Associate\, Patents and Innovations\, Wilson Sonsini \n••• \nDownload the free Zoom app ahead of time to prepare for the webinar
URL:https://scienceinvancouver.com/event/larger-than-life-science-race-for-a-cure-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/LARGER-THAN-LIFE-SCIENCE-Race-for-a-Cure.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200416T130000
DTEND;TZID=America/Vancouver:20200416T134500
DTSTAMP:20260408T195422
CREATED:20200403T202418Z
LAST-MODIFIED:20200403T202418Z
UID:27745-1587042000-1587044700@scienceinvancouver.com
SUMMARY:LARGER THAN LIFE SCIENCE | Race for a Cure
DESCRIPTION:Race for a Cure\nThe Work Behind a Coronavirus Vaccine\nFireside Chat with Claes Gustafsson of ATUM\nAmidst global concerns about the coronavirus outbreak\, Bay Area company ATUM is working around the clock to help find a vaccine. ATUM builds virtual models first to identify different properties of the coronavirus. Sub-pieces of the virus are then sent to collaborators around the world who are working on formulations for a vaccine. In this fireside chat\, hear from ATUM’s Co-Founder\, Claes Gustafsson\, on the technology behind the cure and how the biotech community is banding together for the collective good. \nSpeakers:\nDr. Claes Gustafsson\, Co-Founder and Chief Commercial Officer\, ATUM \nDerrick Rowe\, PhD\, Associate\, Patents and Innovations\, Wilson Sonsini \n••• \nDownload the free Zoom app ahead of time to prepare for the webinar
URL:https://scienceinvancouver.com/event/larger-than-life-science-race-for-a-cure-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/LARGER-THAN-LIFE-SCIENCE-Race-for-a-Cure.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200416T130000
DTEND;TZID=America/Vancouver:20200416T134500
DTSTAMP:20260408T195422
CREATED:20200403T202418Z
LAST-MODIFIED:20200403T202418Z
UID:30828-1587042000-1587044700@scienceinvancouver.com
SUMMARY:LARGER THAN LIFE SCIENCE | Race for a Cure
DESCRIPTION:Race for a Cure\nThe Work Behind a Coronavirus Vaccine\nFireside Chat with Claes Gustafsson of ATUM\nAmidst global concerns about the coronavirus outbreak\, Bay Area company ATUM is working around the clock to help find a vaccine. ATUM builds virtual models first to identify different properties of the coronavirus. Sub-pieces of the virus are then sent to collaborators around the world who are working on formulations for a vaccine. In this fireside chat\, hear from ATUM’s Co-Founder\, Claes Gustafsson\, on the technology behind the cure and how the biotech community is banding together for the collective good. \nSpeakers:\nDr. Claes Gustafsson\, Co-Founder and Chief Commercial Officer\, ATUM \nDerrick Rowe\, PhD\, Associate\, Patents and Innovations\, Wilson Sonsini \n••• \nDownload the free Zoom app ahead of time to prepare for the webinar
URL:https://scienceinvancouver.com/event/larger-than-life-science-race-for-a-cure-4/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/LARGER-THAN-LIFE-SCIENCE-Race-for-a-Cure.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200416T130000
DTEND;TZID=America/Vancouver:20200416T134500
DTSTAMP:20260408T195422
CREATED:20200403T202418Z
LAST-MODIFIED:20200403T202418Z
UID:32288-1587042000-1587044700@scienceinvancouver.com
SUMMARY:LARGER THAN LIFE SCIENCE | Race for a Cure
DESCRIPTION:Race for a Cure\nThe Work Behind a Coronavirus Vaccine\nFireside Chat with Claes Gustafsson of ATUM\nAmidst global concerns about the coronavirus outbreak\, Bay Area company ATUM is working around the clock to help find a vaccine. ATUM builds virtual models first to identify different properties of the coronavirus. Sub-pieces of the virus are then sent to collaborators around the world who are working on formulations for a vaccine. In this fireside chat\, hear from ATUM’s Co-Founder\, Claes Gustafsson\, on the technology behind the cure and how the biotech community is banding together for the collective good. \nSpeakers:\nDr. Claes Gustafsson\, Co-Founder and Chief Commercial Officer\, ATUM \nDerrick Rowe\, PhD\, Associate\, Patents and Innovations\, Wilson Sonsini \n••• \nDownload the free Zoom app ahead of time to prepare for the webinar
URL:https://scienceinvancouver.com/event/larger-than-life-science-race-for-a-cure-5/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/LARGER-THAN-LIFE-SCIENCE-Race-for-a-Cure.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200417T110000
DTEND;TZID=America/Vancouver:20200419T200000
DTSTAMP:20260408T195422
CREATED:20200415T210805Z
LAST-MODIFIED:20200415T210805Z
UID:11105-1587121200-1587326400@scienceinvancouver.com
SUMMARY:Together Vs. Virus Online Hackathon against COVID-19
DESCRIPTION:Inspired by online hackathons against COVID-19 happening in Europe\, a group of incubators\, universities and organizations across Canada including faculty member Scott Mallory’s ISM Arts & Culture have come together to launch Together Vs. Virus for diverse people and innovators to develop ways to address challenges faced in our communities resulting from the pandemic. \nPeople from all backgrounds are invited to work with others on creative solutions for topics including arts & culture; protection of risk groups; dissemination prevention; data & misinformation; economic impact; isolation & mental health; hospital & medical care; family & kids; education; home office & teamwork; crime reduction; support & solidarity; after the crisis and more. Technical know-how is not required\, and participants represent a broad and diverse range of skills and perspectives. \nWays to participate include mentoring for projects\, tackling and answering challenges\, and proposing challenges. The three-day event includes presentations\, how-to sessions\, team-building\, mentoring\, updates\, tech support\, and pitches throughout each day\, and offers morning energizers and evening DJ sets\, concerts\, and live-coding.
URL:https://scienceinvancouver.com/event/together-vs-virus-online-hackathon-against-covid-19/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/Together-vs-virus-online-hackathon-against-COVID19-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200417T110000
DTEND;TZID=America/Vancouver:20200419T200000
DTSTAMP:20260408T195422
CREATED:20200415T210805Z
LAST-MODIFIED:20200415T210805Z
UID:26141-1587121200-1587326400@scienceinvancouver.com
SUMMARY:Together Vs. Virus Online Hackathon against COVID-19
DESCRIPTION:Inspired by online hackathons against COVID-19 happening in Europe\, a group of incubators\, universities and organizations across Canada including faculty member Scott Mallory’s ISM Arts & Culture have come together to launch Together Vs. Virus for diverse people and innovators to develop ways to address challenges faced in our communities resulting from the pandemic. \nPeople from all backgrounds are invited to work with others on creative solutions for topics including arts & culture; protection of risk groups; dissemination prevention; data & misinformation; economic impact; isolation & mental health; hospital & medical care; family & kids; education; home office & teamwork; crime reduction; support & solidarity; after the crisis and more. Technical know-how is not required\, and participants represent a broad and diverse range of skills and perspectives. \nWays to participate include mentoring for projects\, tackling and answering challenges\, and proposing challenges. The three-day event includes presentations\, how-to sessions\, team-building\, mentoring\, updates\, tech support\, and pitches throughout each day\, and offers morning energizers and evening DJ sets\, concerts\, and live-coding.
URL:https://scienceinvancouver.com/event/together-vs-virus-online-hackathon-against-covid-19-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/Together-vs-virus-online-hackathon-against-COVID19-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200417T110000
DTEND;TZID=America/Vancouver:20200419T200000
DTSTAMP:20260408T195422
CREATED:20200415T210805Z
LAST-MODIFIED:20200415T210805Z
UID:27756-1587121200-1587326400@scienceinvancouver.com
SUMMARY:Together Vs. Virus Online Hackathon against COVID-19
DESCRIPTION:Inspired by online hackathons against COVID-19 happening in Europe\, a group of incubators\, universities and organizations across Canada including faculty member Scott Mallory’s ISM Arts & Culture have come together to launch Together Vs. Virus for diverse people and innovators to develop ways to address challenges faced in our communities resulting from the pandemic. \nPeople from all backgrounds are invited to work with others on creative solutions for topics including arts & culture; protection of risk groups; dissemination prevention; data & misinformation; economic impact; isolation & mental health; hospital & medical care; family & kids; education; home office & teamwork; crime reduction; support & solidarity; after the crisis and more. Technical know-how is not required\, and participants represent a broad and diverse range of skills and perspectives. \nWays to participate include mentoring for projects\, tackling and answering challenges\, and proposing challenges. The three-day event includes presentations\, how-to sessions\, team-building\, mentoring\, updates\, tech support\, and pitches throughout each day\, and offers morning energizers and evening DJ sets\, concerts\, and live-coding.
URL:https://scienceinvancouver.com/event/together-vs-virus-online-hackathon-against-covid-19-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/Together-vs-virus-online-hackathon-against-COVID19-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200417T110000
DTEND;TZID=America/Vancouver:20200419T200000
DTSTAMP:20260408T195422
CREATED:20200415T210805Z
LAST-MODIFIED:20200415T210805Z
UID:30839-1587121200-1587326400@scienceinvancouver.com
SUMMARY:Together Vs. Virus Online Hackathon against COVID-19
DESCRIPTION:Inspired by online hackathons against COVID-19 happening in Europe\, a group of incubators\, universities and organizations across Canada including faculty member Scott Mallory’s ISM Arts & Culture have come together to launch Together Vs. Virus for diverse people and innovators to develop ways to address challenges faced in our communities resulting from the pandemic. \nPeople from all backgrounds are invited to work with others on creative solutions for topics including arts & culture; protection of risk groups; dissemination prevention; data & misinformation; economic impact; isolation & mental health; hospital & medical care; family & kids; education; home office & teamwork; crime reduction; support & solidarity; after the crisis and more. Technical know-how is not required\, and participants represent a broad and diverse range of skills and perspectives. \nWays to participate include mentoring for projects\, tackling and answering challenges\, and proposing challenges. The three-day event includes presentations\, how-to sessions\, team-building\, mentoring\, updates\, tech support\, and pitches throughout each day\, and offers morning energizers and evening DJ sets\, concerts\, and live-coding.
URL:https://scienceinvancouver.com/event/together-vs-virus-online-hackathon-against-covid-19-4/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/Together-vs-virus-online-hackathon-against-COVID19-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200417T110000
DTEND;TZID=America/Vancouver:20200419T200000
DTSTAMP:20260408T195422
CREATED:20200415T210805Z
LAST-MODIFIED:20200415T210805Z
UID:32299-1587121200-1587326400@scienceinvancouver.com
SUMMARY:Together Vs. Virus Online Hackathon against COVID-19
DESCRIPTION:Inspired by online hackathons against COVID-19 happening in Europe\, a group of incubators\, universities and organizations across Canada including faculty member Scott Mallory’s ISM Arts & Culture have come together to launch Together Vs. Virus for diverse people and innovators to develop ways to address challenges faced in our communities resulting from the pandemic. \nPeople from all backgrounds are invited to work with others on creative solutions for topics including arts & culture; protection of risk groups; dissemination prevention; data & misinformation; economic impact; isolation & mental health; hospital & medical care; family & kids; education; home office & teamwork; crime reduction; support & solidarity; after the crisis and more. Technical know-how is not required\, and participants represent a broad and diverse range of skills and perspectives. \nWays to participate include mentoring for projects\, tackling and answering challenges\, and proposing challenges. The three-day event includes presentations\, how-to sessions\, team-building\, mentoring\, updates\, tech support\, and pitches throughout each day\, and offers morning energizers and evening DJ sets\, concerts\, and live-coding.
URL:https://scienceinvancouver.com/event/together-vs-virus-online-hackathon-against-covid-19-5/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/Together-vs-virus-online-hackathon-against-COVID19-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200420T090000
DTEND;TZID=America/Vancouver:20200420T100000
DTSTAMP:20260408T195422
CREATED:20200330T211501Z
LAST-MODIFIED:20200330T211501Z
UID:10894-1587373200-1587376800@scienceinvancouver.com
SUMMARY:Webinar: Hematopoietic Cell Therapy Products - Determining Potency and Stability
DESCRIPTION:There are unique challenges when it comes to cell therapy products\, including ensuring the reproducibility and consistency of product lots. These specific concerns arise from the inherent variability of the starting material\, which often comes from multiple patients or donors. Before using these cells as therapy\, the quality–including both purity and potency–of the final product must be established. This in turn requires reliable cell assays.\n\nThe best type of assay to measure the functionality of hematopoietic stem and progenitor cells (HSPCs) is an in vivo mouse model engraftment study; however\, these types of assays are time-consuming\, expensive\, and difficult to evaluate. Therefore\, the in vitro colony-forming unit (CFU) assay\, which has been shown to correlate well with in vivo engraftment models\, is recommended to evaluate the quality of HSPCs used in cell therapy. Several cord blood bank accrediting bodies (including AABB and FACT) now require pre-freeze CFU data from cord blood collection\, as evidence of sample stability and to ensure there is minimal loss of HSPCs during processing and cryopreservation.\n\nIn this webinar\, Dr. Jackie Damen of STEMCELL Technologies will explore the need for standardized potency assays for hematopoietic cell products and review recent publications that evaluate the effects of cryopreservation protocols on the potency of cell therapy products. Dr. Damen will define the CFU assay and explore its utility as part of the cell therapy workflow. She will also define simple steps that can help ensure standardization of the CFU assay\, including the use of automated imaging and analysis of cultures.\n\nLearning Objectives:\n\nDefine the CFU assay and its characteristics as a biological tool in identifying hematopoietic stem and progenitor cells\nIdentify publications using the CFU assay to verify the potency and stability of Hematopoietic Cellular Therapy Products\nUnderstand the utility of the CFU assay in the processing and manufacturing of Hematopoietic Cellular Therapy Products\n\n\n\nWebinars will be available for unlimited on-demand viewing after live event.\n\nLabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar\, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
URL:https://scienceinvancouver.com/event/webinar-hematopoietic-cell-therapy-products-determining-potency-and-stability/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200420T090000
DTEND;TZID=America/Vancouver:20200420T100000
DTSTAMP:20260408T195422
CREATED:20200330T211501Z
LAST-MODIFIED:20200330T211501Z
UID:26124-1587373200-1587376800@scienceinvancouver.com
SUMMARY:Webinar: Hematopoietic Cell Therapy Products - Determining Potency and Stability
DESCRIPTION:There are unique challenges when it comes to cell therapy products\, including ensuring the reproducibility and consistency of product lots. These specific concerns arise from the inherent variability of the starting material\, which often comes from multiple patients or donors. Before using these cells as therapy\, the quality–including both purity and potency–of the final product must be established. This in turn requires reliable cell assays.\n\nThe best type of assay to measure the functionality of hematopoietic stem and progenitor cells (HSPCs) is an in vivo mouse model engraftment study; however\, these types of assays are time-consuming\, expensive\, and difficult to evaluate. Therefore\, the in vitro colony-forming unit (CFU) assay\, which has been shown to correlate well with in vivo engraftment models\, is recommended to evaluate the quality of HSPCs used in cell therapy. Several cord blood bank accrediting bodies (including AABB and FACT) now require pre-freeze CFU data from cord blood collection\, as evidence of sample stability and to ensure there is minimal loss of HSPCs during processing and cryopreservation.\n\nIn this webinar\, Dr. Jackie Damen of STEMCELL Technologies will explore the need for standardized potency assays for hematopoietic cell products and review recent publications that evaluate the effects of cryopreservation protocols on the potency of cell therapy products. Dr. Damen will define the CFU assay and explore its utility as part of the cell therapy workflow. She will also define simple steps that can help ensure standardization of the CFU assay\, including the use of automated imaging and analysis of cultures.\n\nLearning Objectives:\n\nDefine the CFU assay and its characteristics as a biological tool in identifying hematopoietic stem and progenitor cells\nIdentify publications using the CFU assay to verify the potency and stability of Hematopoietic Cellular Therapy Products\nUnderstand the utility of the CFU assay in the processing and manufacturing of Hematopoietic Cellular Therapy Products\n\n\n\nWebinars will be available for unlimited on-demand viewing after live event.\n\nLabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar\, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
URL:https://scienceinvancouver.com/event/webinar-hematopoietic-cell-therapy-products-determining-potency-and-stability-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200420T090000
DTEND;TZID=America/Vancouver:20200420T100000
DTSTAMP:20260408T195422
CREATED:20200330T211501Z
LAST-MODIFIED:20200330T211501Z
UID:27739-1587373200-1587376800@scienceinvancouver.com
SUMMARY:Webinar: Hematopoietic Cell Therapy Products - Determining Potency and Stability
DESCRIPTION:There are unique challenges when it comes to cell therapy products\, including ensuring the reproducibility and consistency of product lots. These specific concerns arise from the inherent variability of the starting material\, which often comes from multiple patients or donors. Before using these cells as therapy\, the quality–including both purity and potency–of the final product must be established. This in turn requires reliable cell assays.\n\nThe best type of assay to measure the functionality of hematopoietic stem and progenitor cells (HSPCs) is an in vivo mouse model engraftment study; however\, these types of assays are time-consuming\, expensive\, and difficult to evaluate. Therefore\, the in vitro colony-forming unit (CFU) assay\, which has been shown to correlate well with in vivo engraftment models\, is recommended to evaluate the quality of HSPCs used in cell therapy. Several cord blood bank accrediting bodies (including AABB and FACT) now require pre-freeze CFU data from cord blood collection\, as evidence of sample stability and to ensure there is minimal loss of HSPCs during processing and cryopreservation.\n\nIn this webinar\, Dr. Jackie Damen of STEMCELL Technologies will explore the need for standardized potency assays for hematopoietic cell products and review recent publications that evaluate the effects of cryopreservation protocols on the potency of cell therapy products. Dr. Damen will define the CFU assay and explore its utility as part of the cell therapy workflow. She will also define simple steps that can help ensure standardization of the CFU assay\, including the use of automated imaging and analysis of cultures.\n\nLearning Objectives:\n\nDefine the CFU assay and its characteristics as a biological tool in identifying hematopoietic stem and progenitor cells\nIdentify publications using the CFU assay to verify the potency and stability of Hematopoietic Cellular Therapy Products\nUnderstand the utility of the CFU assay in the processing and manufacturing of Hematopoietic Cellular Therapy Products\n\n\n\nWebinars will be available for unlimited on-demand viewing after live event.\n\nLabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar\, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
URL:https://scienceinvancouver.com/event/webinar-hematopoietic-cell-therapy-products-determining-potency-and-stability-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200420T090000
DTEND;TZID=America/Vancouver:20200420T100000
DTSTAMP:20260408T195422
CREATED:20200330T211501Z
LAST-MODIFIED:20200330T211501Z
UID:30822-1587373200-1587376800@scienceinvancouver.com
SUMMARY:Webinar: Hematopoietic Cell Therapy Products - Determining Potency and Stability
DESCRIPTION:There are unique challenges when it comes to cell therapy products\, including ensuring the reproducibility and consistency of product lots. These specific concerns arise from the inherent variability of the starting material\, which often comes from multiple patients or donors. Before using these cells as therapy\, the quality–including both purity and potency–of the final product must be established. This in turn requires reliable cell assays.\n\nThe best type of assay to measure the functionality of hematopoietic stem and progenitor cells (HSPCs) is an in vivo mouse model engraftment study; however\, these types of assays are time-consuming\, expensive\, and difficult to evaluate. Therefore\, the in vitro colony-forming unit (CFU) assay\, which has been shown to correlate well with in vivo engraftment models\, is recommended to evaluate the quality of HSPCs used in cell therapy. Several cord blood bank accrediting bodies (including AABB and FACT) now require pre-freeze CFU data from cord blood collection\, as evidence of sample stability and to ensure there is minimal loss of HSPCs during processing and cryopreservation.\n\nIn this webinar\, Dr. Jackie Damen of STEMCELL Technologies will explore the need for standardized potency assays for hematopoietic cell products and review recent publications that evaluate the effects of cryopreservation protocols on the potency of cell therapy products. Dr. Damen will define the CFU assay and explore its utility as part of the cell therapy workflow. She will also define simple steps that can help ensure standardization of the CFU assay\, including the use of automated imaging and analysis of cultures.\n\nLearning Objectives:\n\nDefine the CFU assay and its characteristics as a biological tool in identifying hematopoietic stem and progenitor cells\nIdentify publications using the CFU assay to verify the potency and stability of Hematopoietic Cellular Therapy Products\nUnderstand the utility of the CFU assay in the processing and manufacturing of Hematopoietic Cellular Therapy Products\n\n\n\nWebinars will be available for unlimited on-demand viewing after live event.\n\nLabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar\, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
URL:https://scienceinvancouver.com/event/webinar-hematopoietic-cell-therapy-products-determining-potency-and-stability-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200420T090000
DTEND;TZID=America/Vancouver:20200420T100000
DTSTAMP:20260408T195422
CREATED:20200330T211501Z
LAST-MODIFIED:20200330T211501Z
UID:32282-1587373200-1587376800@scienceinvancouver.com
SUMMARY:Webinar: Hematopoietic Cell Therapy Products - Determining Potency and Stability
DESCRIPTION:There are unique challenges when it comes to cell therapy products\, including ensuring the reproducibility and consistency of product lots. These specific concerns arise from the inherent variability of the starting material\, which often comes from multiple patients or donors. Before using these cells as therapy\, the quality–including both purity and potency–of the final product must be established. This in turn requires reliable cell assays.\n\nThe best type of assay to measure the functionality of hematopoietic stem and progenitor cells (HSPCs) is an in vivo mouse model engraftment study; however\, these types of assays are time-consuming\, expensive\, and difficult to evaluate. Therefore\, the in vitro colony-forming unit (CFU) assay\, which has been shown to correlate well with in vivo engraftment models\, is recommended to evaluate the quality of HSPCs used in cell therapy. Several cord blood bank accrediting bodies (including AABB and FACT) now require pre-freeze CFU data from cord blood collection\, as evidence of sample stability and to ensure there is minimal loss of HSPCs during processing and cryopreservation.\n\nIn this webinar\, Dr. Jackie Damen of STEMCELL Technologies will explore the need for standardized potency assays for hematopoietic cell products and review recent publications that evaluate the effects of cryopreservation protocols on the potency of cell therapy products. Dr. Damen will define the CFU assay and explore its utility as part of the cell therapy workflow. She will also define simple steps that can help ensure standardization of the CFU assay\, including the use of automated imaging and analysis of cultures.\n\nLearning Objectives:\n\nDefine the CFU assay and its characteristics as a biological tool in identifying hematopoietic stem and progenitor cells\nIdentify publications using the CFU assay to verify the potency and stability of Hematopoietic Cellular Therapy Products\nUnderstand the utility of the CFU assay in the processing and manufacturing of Hematopoietic Cellular Therapy Products\n\n\n\nWebinars will be available for unlimited on-demand viewing after live event.\n\nLabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar\, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
URL:https://scienceinvancouver.com/event/webinar-hematopoietic-cell-therapy-products-determining-potency-and-stability-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200420T120000
DTEND;TZID=America/Vancouver:20200420T130000
DTSTAMP:20260408T195422
CREATED:20200417T210158Z
LAST-MODIFIED:20200417T210158Z
UID:11123-1587384000-1587387600@scienceinvancouver.com
SUMMARY:Responding to COVID-19: Opportunities for All Researchers to Engage
DESCRIPTION:Right now\, all eyes are on an urgent science issue and its effects on our society. While everyone has a role to play in reducing the spread of the virus\, scientists have unique opportunities to respond to the crisis in impactful ways. For example\, some scientists might volunteer their lab or data analysis skills. Regardless of discipline\, researchers may find opportunities to pivot their research agenda to address timely and relevant questions. And others might serve as voices for science to amplify evidence\, reduce the spread of misinformation\, and advocate for science-informed approaches to managing the pandemic. This online panel discussion will include researchers from different disciplines who will share ideas for scientists looking to respond in the current moment.
URL:https://scienceinvancouver.com/event/responding-to-covid-19-opportunities-for-all-researchers-to-engage/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200420T120000
DTEND;TZID=America/Vancouver:20200420T130000
DTSTAMP:20260408T195422
CREATED:20200417T210158Z
LAST-MODIFIED:20200417T210158Z
UID:26143-1587384000-1587387600@scienceinvancouver.com
SUMMARY:Responding to COVID-19: Opportunities for All Researchers to Engage
DESCRIPTION:Right now\, all eyes are on an urgent science issue and its effects on our society. While everyone has a role to play in reducing the spread of the virus\, scientists have unique opportunities to respond to the crisis in impactful ways. For example\, some scientists might volunteer their lab or data analysis skills. Regardless of discipline\, researchers may find opportunities to pivot their research agenda to address timely and relevant questions. And others might serve as voices for science to amplify evidence\, reduce the spread of misinformation\, and advocate for science-informed approaches to managing the pandemic. This online panel discussion will include researchers from different disciplines who will share ideas for scientists looking to respond in the current moment.
URL:https://scienceinvancouver.com/event/responding-to-covid-19-opportunities-for-all-researchers-to-engage-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200420T120000
DTEND;TZID=America/Vancouver:20200420T130000
DTSTAMP:20260408T195422
CREATED:20200417T210158Z
LAST-MODIFIED:20200417T210158Z
UID:27758-1587384000-1587387600@scienceinvancouver.com
SUMMARY:Responding to COVID-19: Opportunities for All Researchers to Engage
DESCRIPTION:Right now\, all eyes are on an urgent science issue and its effects on our society. While everyone has a role to play in reducing the spread of the virus\, scientists have unique opportunities to respond to the crisis in impactful ways. For example\, some scientists might volunteer their lab or data analysis skills. Regardless of discipline\, researchers may find opportunities to pivot their research agenda to address timely and relevant questions. And others might serve as voices for science to amplify evidence\, reduce the spread of misinformation\, and advocate for science-informed approaches to managing the pandemic. This online panel discussion will include researchers from different disciplines who will share ideas for scientists looking to respond in the current moment.
URL:https://scienceinvancouver.com/event/responding-to-covid-19-opportunities-for-all-researchers-to-engage-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200420T120000
DTEND;TZID=America/Vancouver:20200420T130000
DTSTAMP:20260408T195422
CREATED:20200417T210158Z
LAST-MODIFIED:20200417T210158Z
UID:30841-1587384000-1587387600@scienceinvancouver.com
SUMMARY:Responding to COVID-19: Opportunities for All Researchers to Engage
DESCRIPTION:Right now\, all eyes are on an urgent science issue and its effects on our society. While everyone has a role to play in reducing the spread of the virus\, scientists have unique opportunities to respond to the crisis in impactful ways. For example\, some scientists might volunteer their lab or data analysis skills. Regardless of discipline\, researchers may find opportunities to pivot their research agenda to address timely and relevant questions. And others might serve as voices for science to amplify evidence\, reduce the spread of misinformation\, and advocate for science-informed approaches to managing the pandemic. This online panel discussion will include researchers from different disciplines who will share ideas for scientists looking to respond in the current moment.
URL:https://scienceinvancouver.com/event/responding-to-covid-19-opportunities-for-all-researchers-to-engage-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200420T120000
DTEND;TZID=America/Vancouver:20200420T130000
DTSTAMP:20260408T195422
CREATED:20200417T210158Z
LAST-MODIFIED:20200417T210158Z
UID:32301-1587384000-1587387600@scienceinvancouver.com
SUMMARY:Responding to COVID-19: Opportunities for All Researchers to Engage
DESCRIPTION:Right now\, all eyes are on an urgent science issue and its effects on our society. While everyone has a role to play in reducing the spread of the virus\, scientists have unique opportunities to respond to the crisis in impactful ways. For example\, some scientists might volunteer their lab or data analysis skills. Regardless of discipline\, researchers may find opportunities to pivot their research agenda to address timely and relevant questions. And others might serve as voices for science to amplify evidence\, reduce the spread of misinformation\, and advocate for science-informed approaches to managing the pandemic. This online panel discussion will include researchers from different disciplines who will share ideas for scientists looking to respond in the current moment.
URL:https://scienceinvancouver.com/event/responding-to-covid-19-opportunities-for-all-researchers-to-engage-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T100000
DTEND;TZID=America/Vancouver:20200421T110000
DTSTAMP:20260408T195422
CREATED:20200326T172703Z
LAST-MODIFIED:20200326T172703Z
UID:10834-1587463200-1587466800@scienceinvancouver.com
SUMMARY:North American Vascular Biology Organization (NAVBO) Online Mini-Symposia
DESCRIPTION:An online mini-symposium featuring four presentations:\n\nRenal stromal netrin-1 signaling drives kidney arterial development (Xiaowu Gu\, UT Southwestern)\nInhibition of Notch signaling in pericytes leads to AVM-like lesions (Taliha Nadeem\, University of Illinois\, Chicago)\nDach1 Promotes Coronary Artery Endothelial Cell Specification (Brian Raftrey\, Stanford University)\nPro-angiogenic properties of Purified Exosome Product (PEP) (Ao Shi\, Mayo Clinic) The session will be moderated by Kayla Bayless\, Texas A&M University
URL:https://scienceinvancouver.com/event/north-american-vascular-biology-organization-navbo-online-mini-symposia/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/03/NAVBO.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T100000
DTEND;TZID=America/Vancouver:20200421T110000
DTSTAMP:20260408T195422
CREATED:20200326T172703Z
LAST-MODIFIED:20200326T172703Z
UID:26117-1587463200-1587466800@scienceinvancouver.com
SUMMARY:North American Vascular Biology Organization (NAVBO) Online Mini-Symposia
DESCRIPTION:An online mini-symposium featuring four presentations:\n\nRenal stromal netrin-1 signaling drives kidney arterial development (Xiaowu Gu\, UT Southwestern)\nInhibition of Notch signaling in pericytes leads to AVM-like lesions (Taliha Nadeem\, University of Illinois\, Chicago)\nDach1 Promotes Coronary Artery Endothelial Cell Specification (Brian Raftrey\, Stanford University)\nPro-angiogenic properties of Purified Exosome Product (PEP) (Ao Shi\, Mayo Clinic) The session will be moderated by Kayla Bayless\, Texas A&M University
URL:https://scienceinvancouver.com/event/north-american-vascular-biology-organization-navbo-online-mini-symposia-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/03/NAVBO.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T100000
DTEND;TZID=America/Vancouver:20200421T110000
DTSTAMP:20260408T195422
CREATED:20200326T172703Z
LAST-MODIFIED:20200326T172703Z
UID:27735-1587463200-1587466800@scienceinvancouver.com
SUMMARY:North American Vascular Biology Organization (NAVBO) Online Mini-Symposia
DESCRIPTION:An online mini-symposium featuring four presentations:\n\nRenal stromal netrin-1 signaling drives kidney arterial development (Xiaowu Gu\, UT Southwestern)\nInhibition of Notch signaling in pericytes leads to AVM-like lesions (Taliha Nadeem\, University of Illinois\, Chicago)\nDach1 Promotes Coronary Artery Endothelial Cell Specification (Brian Raftrey\, Stanford University)\nPro-angiogenic properties of Purified Exosome Product (PEP) (Ao Shi\, Mayo Clinic) The session will be moderated by Kayla Bayless\, Texas A&M University
URL:https://scienceinvancouver.com/event/north-american-vascular-biology-organization-navbo-online-mini-symposia-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/03/NAVBO.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T100000
DTEND;TZID=America/Vancouver:20200421T110000
DTSTAMP:20260408T195422
CREATED:20200326T172703Z
LAST-MODIFIED:20200326T172703Z
UID:30818-1587463200-1587466800@scienceinvancouver.com
SUMMARY:North American Vascular Biology Organization (NAVBO) Online Mini-Symposia
DESCRIPTION:An online mini-symposium featuring four presentations:\n\nRenal stromal netrin-1 signaling drives kidney arterial development (Xiaowu Gu\, UT Southwestern)\nInhibition of Notch signaling in pericytes leads to AVM-like lesions (Taliha Nadeem\, University of Illinois\, Chicago)\nDach1 Promotes Coronary Artery Endothelial Cell Specification (Brian Raftrey\, Stanford University)\nPro-angiogenic properties of Purified Exosome Product (PEP) (Ao Shi\, Mayo Clinic) The session will be moderated by Kayla Bayless\, Texas A&M University
URL:https://scienceinvancouver.com/event/north-american-vascular-biology-organization-navbo-online-mini-symposia-4/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/03/NAVBO.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T100000
DTEND;TZID=America/Vancouver:20200421T110000
DTSTAMP:20260408T195422
CREATED:20200326T172703Z
LAST-MODIFIED:20200326T172703Z
UID:32278-1587463200-1587466800@scienceinvancouver.com
SUMMARY:North American Vascular Biology Organization (NAVBO) Online Mini-Symposia
DESCRIPTION:An online mini-symposium featuring four presentations:\n\nRenal stromal netrin-1 signaling drives kidney arterial development (Xiaowu Gu\, UT Southwestern)\nInhibition of Notch signaling in pericytes leads to AVM-like lesions (Taliha Nadeem\, University of Illinois\, Chicago)\nDach1 Promotes Coronary Artery Endothelial Cell Specification (Brian Raftrey\, Stanford University)\nPro-angiogenic properties of Purified Exosome Product (PEP) (Ao Shi\, Mayo Clinic) The session will be moderated by Kayla Bayless\, Texas A&M University
URL:https://scienceinvancouver.com/event/north-american-vascular-biology-organization-navbo-online-mini-symposia-5/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/03/NAVBO.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T120000
DTEND;TZID=America/Vancouver:20200421T130000
DTSTAMP:20260408T195422
CREATED:20200415T182606Z
LAST-MODIFIED:20200415T182606Z
UID:11094-1587470400-1587474000@scienceinvancouver.com
SUMMARY:Special LINUS Report: Major Updates on Scientific Progress Amidst a Global Pandemic
DESCRIPTION:Having embarked on a longitudinal study to understand the impact of Coronavirus across life sciences\, we have identified four phases for how the pandemic will cause disruptions to the industry. Now\, with a second major data-collection time point\, and over 2\,000 respondents\, we have found major updates on what the life science community is thinking\, feeling and doing as coronavirus continues to affect our realities and shapes productivity. In this next wave of our research\, we will reveal the magnitude of the disruption to productivity\, the progress of workplace transitions\, and the developing sentiment felt across the industry.
URL:https://scienceinvancouver.com/event/special-linus-report-major-updates-on-scientific-progress-amidst-a-global-pandemic/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T120000
DTEND;TZID=America/Vancouver:20200421T130000
DTSTAMP:20260408T195422
CREATED:20200415T182606Z
LAST-MODIFIED:20200415T182606Z
UID:26139-1587470400-1587474000@scienceinvancouver.com
SUMMARY:Special LINUS Report: Major Updates on Scientific Progress Amidst a Global Pandemic
DESCRIPTION:Having embarked on a longitudinal study to understand the impact of Coronavirus across life sciences\, we have identified four phases for how the pandemic will cause disruptions to the industry. Now\, with a second major data-collection time point\, and over 2\,000 respondents\, we have found major updates on what the life science community is thinking\, feeling and doing as coronavirus continues to affect our realities and shapes productivity. In this next wave of our research\, we will reveal the magnitude of the disruption to productivity\, the progress of workplace transitions\, and the developing sentiment felt across the industry.
URL:https://scienceinvancouver.com/event/special-linus-report-major-updates-on-scientific-progress-amidst-a-global-pandemic-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T120000
DTEND;TZID=America/Vancouver:20200421T130000
DTSTAMP:20260408T195422
CREATED:20200415T182606Z
LAST-MODIFIED:20200415T182606Z
UID:27754-1587470400-1587474000@scienceinvancouver.com
SUMMARY:Special LINUS Report: Major Updates on Scientific Progress Amidst a Global Pandemic
DESCRIPTION:Having embarked on a longitudinal study to understand the impact of Coronavirus across life sciences\, we have identified four phases for how the pandemic will cause disruptions to the industry. Now\, with a second major data-collection time point\, and over 2\,000 respondents\, we have found major updates on what the life science community is thinking\, feeling and doing as coronavirus continues to affect our realities and shapes productivity. In this next wave of our research\, we will reveal the magnitude of the disruption to productivity\, the progress of workplace transitions\, and the developing sentiment felt across the industry.
URL:https://scienceinvancouver.com/event/special-linus-report-major-updates-on-scientific-progress-amidst-a-global-pandemic-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T120000
DTEND;TZID=America/Vancouver:20200421T130000
DTSTAMP:20260408T195422
CREATED:20200415T182606Z
LAST-MODIFIED:20200415T182606Z
UID:30837-1587470400-1587474000@scienceinvancouver.com
SUMMARY:Special LINUS Report: Major Updates on Scientific Progress Amidst a Global Pandemic
DESCRIPTION:Having embarked on a longitudinal study to understand the impact of Coronavirus across life sciences\, we have identified four phases for how the pandemic will cause disruptions to the industry. Now\, with a second major data-collection time point\, and over 2\,000 respondents\, we have found major updates on what the life science community is thinking\, feeling and doing as coronavirus continues to affect our realities and shapes productivity. In this next wave of our research\, we will reveal the magnitude of the disruption to productivity\, the progress of workplace transitions\, and the developing sentiment felt across the industry.
URL:https://scienceinvancouver.com/event/special-linus-report-major-updates-on-scientific-progress-amidst-a-global-pandemic-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T120000
DTEND;TZID=America/Vancouver:20200421T130000
DTSTAMP:20260408T195422
CREATED:20200415T182606Z
LAST-MODIFIED:20200415T182606Z
UID:32297-1587470400-1587474000@scienceinvancouver.com
SUMMARY:Special LINUS Report: Major Updates on Scientific Progress Amidst a Global Pandemic
DESCRIPTION:Having embarked on a longitudinal study to understand the impact of Coronavirus across life sciences\, we have identified four phases for how the pandemic will cause disruptions to the industry. Now\, with a second major data-collection time point\, and over 2\,000 respondents\, we have found major updates on what the life science community is thinking\, feeling and doing as coronavirus continues to affect our realities and shapes productivity. In this next wave of our research\, we will reveal the magnitude of the disruption to productivity\, the progress of workplace transitions\, and the developing sentiment felt across the industry.
URL:https://scienceinvancouver.com/event/special-linus-report-major-updates-on-scientific-progress-amidst-a-global-pandemic-5/
LOCATION:Online
END:VEVENT
END:VCALENDAR